Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials

Marthe Kirkesæther Brun, Johanna Elin Gehin, K. H. Bjørlykke, David J. Warren, Rolf Anton Klaasen, Joseph Sexton, Øystein Sandanger, Tore K Kvien, Cato Mørk, Jørgen Jahnsen,

The Lancet Rheumatology · 2024 · 15 citations · 20 references

Concepts

References

20